From Nasdaq: 2025-02-13 16:24:10

Pacific Biosciences of California, Inc. reported earnings of $3.57 million in Q4, a significant improvement from -$82.02 million in the same period last year. However, the EPS decreased to -$0.49 from -$0.31. Excluding items, the company reported adjusted earnings of -$55.34 million or -$0.20 per share. Analysts had projected a slightly better EPS of -$0.17. Revenue also saw a decline, with $39.22 million in Q4 compared to $58.36 million in the same period last year.



Read more at Nasdaq: Pacific Biosciences Of California, Inc. Q4 Earnings Summary